PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 3, 2013Annals of Internal Medicine329 citations

Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians

View Full Paper
AQAmir QaseemLHLinda L. HumphreyNFNick Fitterman

Key Points

  • Provide evidence-based clinical guidance on managing anemia in patients with congestive heart failure or coronary heart disease.
  • Clinical practice guideline developed by the American College of Physicians evaluating treatments for anemia in heart disease.
  • Assessed the safety and efficacy evidence for erythropoiesis-stimulating agents in populations with mild to moderate anemia.
  • The American College of Physicians recommends against using erythropoiesis-stimulating agents in patients with mild to moderate anemia and congestive heart failure or coronary heart disease (strong recommendation, moderate-quality evidence).

Abstract

ACP recommends against the use of erythropoiesis-stimulating agents in patients with mild to moderate anemia and congestive heart failure or coronary heart disease. (Grade: strong recommendation; moderate-quality evidence).

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Qaseem et al. (2013) studied this question.

synapsesocial.com/papers/69d959a85e5bcb4e3b835addhttps://doi.org/10.7326/0003-4819-159-11-201312030-00009
Ask AI
Helpful
Bookmark
Share
View Full Paper